CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric (NYSE:GE), announced today that it has completed a license agreement with NorDiag ASA, (OSE:NORD) granting NorDiag ASA access to GE Healthcare patents for the biomagnetic isolation of nucleic acids. The license, which is valid for the lifetime of the patents, grants NorDiag ASA certain rights with respect to the isolation and purification of nucleic acids using GE Healthcare’s proprietary magnetic separation technology.
